Predicting futile recanalization after mechanical thrombectomy in patients with ischemic stroke and cancer: the CACTUS nomogram
Authors:
- Carlota Villar-RodríguezCVCarlota Villar-Rodríguez
- Luis Fernández EspigaresLELuis Fernández Espigares
- Luis Manzano-HernándezLMLuis Manzano-Hernández
- Manuel Medina-RodriguezMMManuel Medina-Rodriguez
- Pablo Baena PalominoPPPablo Baena Palomino
- Leire Ainz-GómezLALeire Ainz-Gómez
- Marta Aguilar-PerezMAMarta Aguilar-Perez
- Asier de Albóniga-ChindurzaAAAsier de Albóniga-Chindurza
- 18 September 2026
- journal article
- Published by BMJ in Journal of NeuroInterventional Surgery
Abstract
Background: Patients with large vessel occlusion (LVO) and a history of cancer have worse long-term outcomes after mechanical thrombectomy (MT) despite similar reperfusion rates. We aimed to develop a clinical prognostic score to predict futile recanalization (FR) in this population. Methods: We retrospectively analyzed a single-center prospective registry (ARTISTA) of patients with LVO and active or previous cancer who underwent MT between January 2021 and December 2023. The primary outcome was FR, defined as successful angiographic reperfusion (expanded Thrombolysis in Cerebral Infarction (eTICI) ≥2b) with poor functional outcome (modified Rankin Scale (mRS) ≥3) at 90 days. A clinically prespecified logistic regression model was developed to predict FR. Model performance was assessed, and internal validation was performed using bootstrap resampling and repeated cross-validation. An expanded penalized least absolute shrinkage and selection operator (LASSO) model was evaluated as a secondary analysis and a nomogram was derived from the final model. Results: Of 1584 patients who underwent MT during the study period, 167 patients with a history of cancer met the eligibility criteria for analysis. FR occurred in 50.9% of patients. A clinically prespecified prediction model included age, pre-stroke mRS score, admission National Institutes of Health Stroke Scale (NIHSS) score, and metastatic disease. A higher pre-stroke mRS score (adjusted OR (aOR) 1.84, 95% CI 1.09 to 3.21; P=0.025), higher admission NIHSS score (aOR 1.11 per point, 95% CI 1.05 to 1.17; P<0.001), and metastatic disease (aOR 8.38, 95% CI 2.77 to 31.93; P<0.001) were independently associated with FR. Internal bootstrap validation yielded an optimism-corrected AUC of 0.758 and a Brier score of 0.206. An optimism-corrected nomogram was derived for clinical use. Conclusion: The CACTUS prediction model showed adequate predictive performance for FR, and the derived nomogram may serve as a practical tool for individualized risk assessment in patients with LVO who are candidates for MT and have a history of cancer.Keywords
Funding Information
- Instituto de Salud Carlos III (JR25/00035 (Manuel Medina))
- Instituto de Salud Carlos III (PI24/01319 and RD24/0009/0007)
This publication has 28 references indexed in Scilit:
- Stroke risk in cancer survivors: A meta-analysis and meta regressionNeurological Sciences, 2025
- Quality-of-life, concerns, and treatment priorities in patients with cancer-related ischemic stroke: A prospective survey studyJournal of Stroke and Cerebrovascular Diseases, 2023
- Temporal trends and outcomes in acute ischaemic stroke patients with a current or historical diagnosis of cancerEuropean Journal of Neurology, 2023
- Efficacy of mechanical thrombectomy in patients with ischemic stroke and cancerJournal of Clinical Neuroscience, 2021
- Endovascular Therapy of Acute Ischemic Stroke in Patients with Large-Vessel Occlusion Associated with Active MalignancyJournal of Stroke and Cerebrovascular Diseases, 2021
- Intra-arterial thrombectomy for acute ischaemic stroke patients with active cancerJournal of Neurology, 2019
- Ischemic stroke in cancer patients: A review of an underappreciated pathologyAnnals of Neurology, 2018
- Risk of Cerebrovascular Events in 178 962 Five-Year Survivors of Cancer Diagnosed at 15 to 39 Years of AgeCirculation, 2017
- Predictors of survival for patients with cancer after cryptogenic strokeJournal of Neuro-Oncology, 2016
- Risk of haemorrhagic and ischaemic stroke in patients with cancer: A nationwide follow-up study from SwedenEuropean Journal of Cancer, 2012